OpenVSafe by OpenVAERS
Search V-safe

V7A-18457-83952

3 vaccinations 4 coded responses 33 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
787 / TX
Registered
2021-04-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-01
    Registered in v-safe
  2. 2021-04-01
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-01
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-08
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-15
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-22
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-22
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-04-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-29
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-06
    Survey response — day 14, dose 2
    MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: Good · Be unable to do your normal daily activities
    Free text: More intense and longer period than usual (heavier flow, more painful and longer lasting cramps).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-20
    Survey response — day 28, dose 2
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Had a cold
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-07-24
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-10-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-11-22
    Dose 3 — Pfizer-BioNTech
  25. 2021-11-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  26. 2021-11-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  27. 2021-11-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Swollen supraclavicular lymph node
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-11-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Headache
    Free text: Slight swelling in supraclavicular lymph node
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-12-01
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-12-08
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-12-13
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-12-22
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-12-27
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-01-03
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-05-23
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-11-24
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Pfizer-BioNTech
22021-04-22Pfizer-BioNTech
32021-11-22Pfizer-BioNTech No

Free text

Release 8 — day 14, dose 2

2021-05-06

Symptoms: More intense and longer period than usual (heavier flow, more painful and longer lasting cramps).

Release 8 — day 28, dose 2

2021-05-20

Symptoms: Had a cold

Release 10 — days 1–6 daily, dose 3

2021-11-25

Systemic reaction (other): Swollen supraclavicular lymph node

2021-11-27

Systemic reaction (other): Slight swelling in supraclavicular lymph node

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDysmenorrhoea ✓ ✓ ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDNasopharyngitis ✓ ✓ ✓
SROLymphadenopathy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…